Nancy J. Zeleznik‐Le

5.5k total citations
68 papers, 4.2k citations indexed

About

Nancy J. Zeleznik‐Le is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nancy J. Zeleznik‐Le has authored 68 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 35 papers in Hematology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nancy J. Zeleznik‐Le's work include Acute Myeloid Leukemia Research (33 papers), RNA Interference and Gene Delivery (12 papers) and Genomics and Chromatin Dynamics (11 papers). Nancy J. Zeleznik‐Le is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), RNA Interference and Gene Delivery (12 papers) and Genomics and Chromatin Dynamics (11 papers). Nancy J. Zeleznik‐Le collaborates with scholars based in United States, Japan and Spain. Nancy J. Zeleznik‐Le's co-authors include Janet D. Rowley, Alanna M. Harden, Relja Popovic, Manuel O. Dı́az, Mitsuhiko Osaka, Shalini C. Reshmi, Pamela L. Strissel, Nicholas J. Achille, Jenny P.‐Y. Ting and Zhenbiao Xia and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nancy J. Zeleznik‐Le

65 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy J. Zeleznik‐Le United States 32 3.2k 1.3k 568 559 460 68 4.2k
Takaomi Sanda Singapore 35 3.1k 1.0× 916 0.7× 849 1.5× 767 1.4× 1.0k 2.3× 108 4.5k
Marc R. Mansour United Kingdom 26 1.9k 0.6× 651 0.5× 347 0.6× 316 0.6× 557 1.2× 59 2.9k
Eric H. Westin United States 28 2.2k 0.7× 462 0.3× 397 0.7× 759 1.4× 819 1.8× 66 3.6k
Anupama Narla United States 22 3.0k 1.0× 1.1k 0.8× 266 0.5× 425 0.8× 738 1.6× 53 3.9k
Valeria Tosello Italy 26 1.5k 0.5× 555 0.4× 328 0.6× 1.1k 2.0× 782 1.7× 59 3.1k
Junwei Shi United States 35 6.2k 2.0× 1.5k 1.1× 808 1.4× 513 0.9× 1.3k 2.9× 105 7.3k
Peter D. Aplan United States 48 4.4k 1.4× 2.3k 1.7× 549 1.0× 1.1k 1.9× 899 2.0× 155 6.4k
James C. Mulloy United States 41 4.0k 1.3× 2.5k 1.9× 677 1.2× 2.0k 3.5× 1.3k 2.8× 114 6.7k
Wilhelm G. Dirks Germany 28 1.8k 0.6× 407 0.3× 436 0.8× 463 0.8× 796 1.7× 76 3.1k
Cassandra J. Vandenberg Australia 19 2.2k 0.7× 301 0.2× 345 0.6× 553 1.0× 912 2.0× 44 2.9k

Countries citing papers authored by Nancy J. Zeleznik‐Le

Since Specialization
Citations

This map shows the geographic impact of Nancy J. Zeleznik‐Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy J. Zeleznik‐Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy J. Zeleznik‐Le more than expected).

Fields of papers citing papers by Nancy J. Zeleznik‐Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy J. Zeleznik‐Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy J. Zeleznik‐Le. The network helps show where Nancy J. Zeleznik‐Le may publish in the future.

Co-authorship network of co-authors of Nancy J. Zeleznik‐Le

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy J. Zeleznik‐Le. A scholar is included among the top collaborators of Nancy J. Zeleznik‐Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy J. Zeleznik‐Le. Nancy J. Zeleznik‐Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Charles, Nicholas J. Achille, Aravinda Kuntimaddi, et al.. (2020). BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity. Blood Cancer Discovery. 1(2). 162–177. 18 indexed citations
2.
Zeleznik‐Le, Nancy J., et al.. (2016). The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1. Leukemia Research. 46. 51–60. 8 indexed citations
3.
Kuntimaddi, Aravinda, Nicholas J. Achille, Jeremy Thorpe, et al.. (2015). Degree of Recruitment of DOT1L to MLL-AF9 Defines Level of H3K79 Di- and Tri-methylation on Target Genes and Transformation Potential. Cell Reports. 11(5). 808–820. 87 indexed citations
4.
Seet, Christopher S., Clare Sun, Jing Li, et al.. (2013). p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL‐leukemia. Molecular Oncology. 7(6). 1069–1082. 17 indexed citations
5.
Kuntimaddi, Aravinda, et al.. (2013). Functional Specificity of CpG DNA-binding CXXC Domains in Mixed Lineage Leukemia. Journal of Biological Chemistry. 288(41). 29901–29910. 26 indexed citations
6.
Zook, Erin C., Paulette A. Krishack, Shubin Zhang, et al.. (2011). Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells. Blood. 118(22). 5723–5731. 116 indexed citations
7.
Wu, Hongyu, Nicholas J. Achille, Mary Rose Reisenauer, et al.. (2010). Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes. Cancer Research. 70(24). 10234–10242. 133 indexed citations
8.
Cierpicki, Tomasz, Jolanta Grembecka, Stephen M. Lukasik, et al.. (2009). Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia. Nature Structural & Molecular Biology. 17(1). 62–68. 144 indexed citations
9.
Chen, Jing, Donna A. Santillan, Wei Wei, et al.. (2008). Loss of MLL PHD Finger 3 Is Necessary for MLL-ENL–Induced Hematopoietic Stem Cell Immortalization. Cancer Research. 68(15). 6199–6207. 45 indexed citations
10.
Popovic, Relja, Frank Erfurth, & Nancy J. Zeleznik‐Le. (2007). Transcriptional complexity of the HOXA9 locus. Blood Cells Molecules and Diseases. 40(2). 156–159. 20 indexed citations
11.
Santillan, Donna A., Catherine Theisler, Relja Popovic, et al.. (2006). Bromodomain and Histone Acetyltransferase Domain Specificities Control Mixed Lineage Leukemia Phenotype. Cancer Research. 66(20). 10032–10039. 21 indexed citations
12.
Popovic, Relja & Nancy J. Zeleznik‐Le. (2005). MLL: How complex does it get?. Journal of Cellular Biochemistry. 95(2). 234–242. 71 indexed citations
13.
Zhang, Yanming, Nancy J. Zeleznik‐Le, Nimanthi Jayathilaka, et al.. (2004). Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16). Genes Chromosomes and Cancer. 41(3). 257–265. 22 indexed citations
14.
Mujtaba, Shiraz, Yan He, Lei Zeng, et al.. (2004). Structural Mechanism of the Bromodomain of the Coactivator CBP in p53 Transcriptional Activation. Molecular Cell. 13(2). 251–263. 259 indexed citations
15.
Xia, Zhenbiao, et al.. (2003). MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proceedings of the National Academy of Sciences. 100(14). 8342–8347. 140 indexed citations
16.
Smith, Lydia L., Loretta S. Li, Pamela L. Strissel, et al.. (2003). Polymorphisms in the MLL breakpoint cluster region (BCR). Human Genetics. 113(1). 80–91. 13 indexed citations
17.
Odero, María D., Nancy J. Zeleznik‐Le, Vandana Chinwalla, & Janet D. Rowley. (2000). Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation.. PubMed. 29(4). 333–8. 48 indexed citations
18.
Strissel, Pamela L., Reiner Strick, Janet D. Rowley, & Nancy J. Zeleznik‐Le. (1998). An In Vivo Topoisomerase II Cleavage Site and a DNase I Hypersensitive Site Colocalize Near Exon 9 in the MLLBreakpoint Cluster Region. Blood. 92(10). 3793–3803. 119 indexed citations
19.
Rowley, Janet D., Shalini C. Reshmi, John Anastasi, et al.. (1997). All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.. Blood. 90(2). 535–41. 168 indexed citations
20.
Strissel, Pamela L., Dennis Burian, Shalini C. Reshmi, et al.. (1997). Identification of complex genomic breakpoint junctions in the t(9;11) MLL‐AF9 fusion gene in acute leukemia. Genes Chromosomes and Cancer. 20(2). 185–195. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takaomi Sanda Breakdown of academic impact, for papers by Marc R. Mansour Breakdown of academic impact, for papers by Eric H. Westin Breakdown of academic impact, for papers by Anupama Narla Breakdown of academic impact, for papers by Valeria Tosello Breakdown of academic impact, for papers by Junwei Shi Breakdown of academic impact, for papers by Peter D. Aplan Breakdown of academic impact, for papers by James C. Mulloy Breakdown of academic impact, for papers by Wilhelm G. Dirks Breakdown of academic impact, for papers by Cassandra J. Vandenberg
Rankless by CCL
2026